Clinical Trial Update: Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Natura-Alpha for efficacy and tolerability in active ulcerative colitis. The current status of the trial is listed as UNKNOW…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Natura-Alpha

Snippet

Sponsor: Natrogen Therapeutics International, Inc | Conditions: Ulcerative Colitis | Phase 2 | Status: UNKNOWN